Mahesh R. Nepal

MedicineBiochemistry, Genetics and Molecular BiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy”.

Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy

JCI Insight(2023)10.1172/jci.insight.164646

N/A

0.416DataRank · unranked

15 citations

Thomas Drabison, Mahesh R. Nepal, Richard H. Ho, Alix F. Leblanc, Alice A. Gibson +20 more

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0172

N/A

0.385DataRank · unranked

12 citations

Hanieh Taheri, Yang Li, Zahra Talebi, Muhammad Erfan Uddin, Yan Jin +6 more

MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia

International Journal of Molecular Sciences(2022)10.3390/ijms23158607

N/A

0.360DataRank · unranked

10 citations

Eric D. Eisenmann, Yang Li, Kevin M. Huang, Dominique A. Garrison, Zahra Talebi +21 more

Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0332

N/A

0.345DataRank · unranked

9 citations

Mike Boeckman, Yan Yang, Kevin M. Huang, Peter de Bruijn, Mahesh R. Nepal +11 more

Drug–Drug Interaction Liabilities with BTK Inhibitor TL-895

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0265

N/A

0DataRank · unranked

1 citations

Eman Ahmed, Thomas Drabison, Mahesh R. Nepal, Anika T. Chowdhury, Shelley Orwick +6 more